Order Now For Fast Delivery!
This website uses cookies to enhance the user experience. Some cookies are essential for the use of the site. View our Privacy Policy and Cookie Policy for more information.
Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
32. Trazodone for Sleep in OUD
32. Trazodone for Sleep in OUD
Monday 20th November 2023
Learn about trazodone's potential to enhance sleep quality in opioid use disorder patients on buprenorphine in this insightful episode.
26 minutes
Informative
Hopeful
Empowering
Supportive
Thought-provoking
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
We believe that addiction is a disease that can be treated, and we want to help you stay up to date with the latest research that you can use in your addiction medicine practice.
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
69 (View all)
Do you want to link to this podcast?
Get the buttons here!Trazodone and Sleep: A Game-Changer for Opioid Use Disorder?
Episode Overview
- Trazodone effectively improves sleep quality in individuals with opioid use disorder maintained on buprenorphine
- The clinical trial was a randomized double-blind placebo-controlled study with positive outcomes
- The study population was relatively narrow, limiting direct applicability to diverse patient populations
- The hosts critically evaluate the trial's validity, recognizing the potential for confident trazodone recommendations in specific patient subsets
- The findings highlight the medication's potential to address sleep disturbances in addiction medicine practice
So with this data on hand, I really do think I could continue to recommend trazodone confidently as an option for insomnia for patients on buprenorphine.
Can a common antidepressant help those with opioid use disorder sleep better? In this episode of the 'Addiction Medicine Journal Club', Dr. Sonya Del Tredici and Dr. John Keenan dive into a fascinating study on trazodone, a medication often used for sleep disturbances. They explore its impact on patients with opioid use disorder who are maintained on buprenorphine, a common treatment for addiction.
The hosts break down the study's objectives, the patient demographics, and the results, which show promising improvements in sleep quality with minimal side effects. But that’s not all. The episode also touches on the decriminalization of psychedelics and the latest recommendations for managing Hepatitis C in primary care settings. Whether you're a healthcare professional or someone interested in the latest addiction treatment research, this episode offers valuable insights into how trazodone could potentially benefit those struggling with opioid use disorder.
Tune in for an engaging discussion that combines rigorous science with practical applications, making complex topics accessible and relevant.